Vroman Ken

CME Chief Transformation Officer sells 5,160 shares at $309.00 for $1.6M; reduces stake to 14.9K shares (-25.7%)

Vroman Ken, Chief Transformation Officer at CME GROUP INC., sold 5,160 shares at $309.00 on 2026-03-12, reducing his holdings from 20,070 to 14,910 shares—a 25.7% reduction. The sale occurred at a price $2.19 below the current price of $311.19, and 4.7% below the 52-week high of $326.46. His cross-ticker track record shows an average 90-day return of +6.5% after prior sales, indicating his past open-market sell transactions have been poorly timed (stock subsequently rose). At CME specifically, his single prior sale on 2025-02-13 posted identical return metrics (+3.5% at 30 days, +6.5% at 90 days), with 0 of 1 prior CME sells classified as well-timed. The company fundamentals remain robust—$1.5B latest quarterly revenue, $908.0M net income, and a P/E of 5.04—providing no obvious distress signal. The transaction size and moderate reduction in holdings offer limited insight into executive-level conviction.

CME Chief Transformation Officer Ken Vroman sold 5,066 shares at $250.00 for $1,266,500.00 on 2025-02-13.

Ken Vroman, CME's Chief Transformation Officer, sold 5,066 shares representing 23.3% of his pre-transaction holdings on 2025-02-13 at $250.00 per share, reducing his position from 21,781 to 16,715 shares. The sale occurred near the 52-week high of $250.11, with the stock trading at $245.48 currently. CME demonstrates strong fundamental performance with latest quarterly revenue of $1,584,400,000.00, net income of $912,800,000.00, annual revenue growth of +11.2%, and a low P/E of 5.01. The transaction size is material relative to his personal holdings, though no prior trading pattern or scheduled plan information is disclosed in this filing to contextualize the timing or motivation.